לויטרה 10 מ"ג טבליות מסיסות Ізраїль - іврит - Ministry of Health

לויטרה 10 מ"ג טבליות מסיסות

bayer israel ltd - vardenafil as hydrochloride trihydrate 10 mg - tablets orodispersible - vardenafil - treatment of erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. in order for levitra to be effective, sexual stimulation is required. not indicated for use by women.

ציפרוקסין 200 Ізраїль - іврит - Ministry of Health

ציפרוקסין 200

bayer israel ltd - ciprofloxacin as lactate 0.2 g / 100 ml - solution for infusion - ciprofloxacin - adults:uncomplicated and complicated infections caused by ciprofloxacin sensitive pathogens.children: for the treatment of acute pulmonary exacerbation of cystic fibrosis associated with pseudomonas aeroginosa infections in pediatric patients aged 5-17 years.

מגאקסין טבליות Ізраїль - іврит - Ministry of Health

מגאקסין טבליות

bayer israel ltd - moxifloxacin as hydrochloride - טבליות מצופות פילם - moxifloxacin as hydrochloride 0.4 g - moxifloxacin - moxifloxacin - for the treatment of the following bacterial infections: respiratory infections: bronchitis: acute exacerbation of chronic bronchitis ; pneumonia: community acquired ; sinusitis: acute uncomplicated; community-acquired spontaneous and wound infections of the skin and skin structure.

מגאקסין טבליות Ізраїль - іврит - Ministry of Health

מגאקסין טבליות

bayer israel ltd - moxifloxacin as hydrochloride - טבליות מצופות פילם - moxifloxacin as hydrochloride 0.4 g - moxifloxacin - moxifloxacin - for the treatment of the following bacterial infections: respiratory infections: bronchitis: acute exacerbation of chronic bronchitis ; pneumonia: community acquired ; sinusitis: acute uncomplicated; community-acquired spontaneous and wound infections of the skin and skin structure.

מגאקסין IV Ізраїль - іврит - Ministry of Health

מגאקסין iv

bayer israel ltd - moxifloxacin as hydrochloride - תמיסה לאינפוזיה - moxifloxacin as hydrochloride 1.6 mg/ml - moxifloxacin - moxifloxacin - megaxin iv is indicated for the treatment of adults (> 18 years of age) with community acuired pneumonia caused by streptococcus pneumoniae, haemophilus influenzae, moraxella catarrhalis, staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae or chlamydia pneumoniae and complicated skin and skin structure infections caused by methicillin susceptible staphylococus aureus, escherichia coli, klebsiella pneumoniae or enterobacter cloacae. appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin may be initiated before results of these tests are known; once results become available ,appropriate therapy should be continued.

סטיוורגה Ізраїль - іврит - Ministry of Health

סטיוורגה

bayer israel ltd - regorafenib - טבליות מצופות פילם - regorafenib 40 mg - regorafenib - regorafenib - stivarga is indicated for the treatment of patients with metastatic colorectal cancer (crc) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-vegf therapy, and if kras wild-type, an anti-egfr therapy.for the treatment of patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumors (gist) who have been previously treated with imatinib mesylate and sunitinib malate

אספירין C Ізраїль - іврит - Ministry of Health

אספירין c

bayer israel ltd - acetylsalicylic acid; ascorbic acid - טבליה תוססת - acetylsalicylic acid 400 mg; ascorbic acid 240 mg - acetylsalicylic acid - acetylsalicylic acid - pain relief, fever reduction, antirheumatic treatment.

זבלין Ізраїль - іврит - Ministry of Health

זבלין

bayer israel ltd - ibritumomab tiuxetan 1.6 mg/ml - kit for radiopharmaceutical preparation infusion - ibritumomab tiuxetan(90y) - the 90y radiolabelled zevalin is indicated as consolidation therapy after remission induction in previously untreated patients with follicular lymphoma. the benefit of zevalin following rituximab in combination with chemotherapy has not been established.the 90y - radiolabelled zevalin is indicated for the treatment of adult patients with rituximab relapsed or refractory cd20+ follicular b-cell non-hodgkin's lymphama ( nhl).

אדמפאס 0.5 מג Ізраїль - іврит - Ministry of Health

אדמפאס 0.5 מג

bayer israel ltd - riociguat - טבליות מצופות פילם - riociguat 0.5 mg - riociguat

אדמפאס 0.5 מג Ізраїль - іврит - Ministry of Health

אדמפאס 0.5 מג

bayer israel ltd - riociguat - טבליות מצופות פילם - riociguat 0.5 mg - riociguat